FDA Drugs (New Approvals & NDA)Original article
PReye, LLC - 732141 - 08/18/2026
RegulatoryrejectedNegative
AI Analysis
Summary
PReye, LLC received an FDA enforcement action (732141) dated 08/18/2026 for CGMP violations involving adulterated and unapproved finished pharmaceutical products.
Outcome Details
CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug violation
Importance:4/10
Sentiment:
-0.90
FDA enforcementCGMP violationunapproved drugadulterated product
Read the original article
Published by FDA Drugs (New Approvals & NDA) on September 1, 2026 1:20 PM